Attached files

file filename
S-1 - S-1 - ATOSSA THERAPEUTICS, INC.v197816_s1.htm
EX-3.3 - EX-3.3 - ATOSSA THERAPEUTICS, INC.v197816_ex3-3.htm
EX-3.1 - EX-3.1 - ATOSSA THERAPEUTICS, INC.v197816_ex3-1.htm
EX-10.3 - EX-10.3 - ATOSSA THERAPEUTICS, INC.v197816_ex10-3.htm
EX-10.2 - EX-10.2 - ATOSSA THERAPEUTICS, INC.v197816_ex10-2.htm
EX-10.6 - EX-10.6 - ATOSSA THERAPEUTICS, INC.v197816_ex10-6.htm
EX-99.1 - EX-99.1 - ATOSSA THERAPEUTICS, INC.v197816_ex99-1.htm
EX-10.1 - EX-10.1 - ATOSSA THERAPEUTICS, INC.v197816_ex10-1.htm
EX-10.4 - EX-10.4 - ATOSSA THERAPEUTICS, INC.v197816_ex10-4.htm
EX-23.1 - EX-23.1 - ATOSSA THERAPEUTICS, INC.v197816_ex23-1.htm
EX-99.2 - EX-99.2 - ATOSSA THERAPEUTICS, INC.v197816_ex99-2.htm
EX-10.13 - EX-10.13 - ATOSSA THERAPEUTICS, INC.v197816_ex10-13.htm
EX-10.12 - EX-10.12 - ATOSSA THERAPEUTICS, INC.v197816_ex10-12.htm
EX-10.10 - EX-10.10 - ATOSSA THERAPEUTICS, INC.v197816_ex10-10.htm
EX-10.11 - EX-10.11 - ATOSSA THERAPEUTICS, INC.v197816_ex10-11.htm
 
EXHIBIT 99.3
 
ATOSSA GENETICS INC.
 
CONSENT OF PROSPECTIVE DIRECTOR
 
I, Alexander Cross, Ph.D., hereby consent to be named as a prospective director of Atossa Genetics Inc. (the “Company”) in the Registration Statement on Form S-1 of the Company to be filed in connection with the initial public offering of the Company’s securities, and in any amendments thereto.
 
Alexander Cross, Ph.D.
 
Dated:  September 28, 2010